Skip to content
Screener

McKesson MCK Other, net

Other, net at other companies

Eli Lilly logo
Eli LillyLLY
-$4M+87.1%
AbbVie logo
AbbVieABBV
$2M-97.0%
Viatris logo
ViatrisVTRS
-$24.5M+46.0%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
-$69M+9.2%
Stryker logo
StrykerSYK
-$147M-2,350%
Baxter International logo
Baxter InternationalBAX
-$14M+41.7%

Other financials

Income statement

See full
Revenue$105.38B+7.7%
Gross profit$3.7B+12.4%
Operating income$1.3B+27.3%
Net income$614.0M-21.7%
EPS (diluted)$5.15-17.6%

Balance sheet

See full
Cash & equivalents$5.3B+95.9%
Total debt$13.0B+15.7%
Total equity-$4.2B-116%
Total assets$88.3B+8.6%

Cash flow

See full
Operating cash flow-$220.0M+76.0%
CapEx$112.0M+0.9%
Free cash flow-$332.0M+67.7%

Valuation

See full
Market cap$101.59B+15.6%
Enterprise value$109.31B+13.4%
P/E22.1×-5.7×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%+0.1pp
Operating margin1.6%+0.4pp
Net margin1.1%+0.3pp
FCF margin1.6%0.0pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.

The source filing: McKesson’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:29 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000927653-26-000234
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025
Share repurchases(2,530)(581)
Dividends paid(102)(90)
Sale of noncontrolling interest in Medical-Surgical Solutions, net1,238
Other(211)(165)
Net cash provided by financing activities1,6321,176
Effect of exchange rate changes on cash, cash equivalents, and restricted cash(10)33
Net increase (decrease) in cash, cash equivalents, and restricted cash1,188(3,273)
Cash, cash equivalents, and restricted cash at beginning of period4,0685,956

Item 1. Condensed Consolidated Financial Statements.

FAQ

What is McKesson's other, net?
McKesson (MCK) reported other, net of -$211M in Q2 2026.
How has McKesson's other, net changed year-over-year?
McKesson's other, net decreased by 27.9% year-over-year, from -$165M to -$211M.
What is the long-term trend for McKesson's other, net?
Over 3 years (2022 to 2026), McKesson's other, net has grown at a -1.0% compound annual growth rate (CAGR), from -$383M to -$372M.
What does other, net mean?
Includes miscellaneous cash flows related to financing activities that are not categorized as debt issuance, dividends, or share repurchases. This may include changes in non-controlling interests, debt issuance costs, or other unique financing-related transactions. It provides a comprehensive view of non-standard financing cash movements.

Ask your AI about McKesson's other, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude